Genprex Inc. Shows Resilience and Growth Potential Amid Biotech Market Volatility
Genprex Inc. is a biotech company pioneering immunogene therapies for cancer treatment, showing resilience and potential for growth despite market challenges, and poised to drive further advancements in cancer therapy.
2 minutes to read